Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Henry Schein, Inc. HSIC

Healthcare  —  Medical Distribution
86.37 0.84 0.98% as of 25 Sep
Market cap
$9.5B
P/E
25.0×
S&P 500 Member Insider Buys (last 12m)
Indexes indicate stock being part of an index,
Insider Buys alert about insiders buying in the last 12 month
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Henry Schein, Inc. (HSIC) Business Profile

Updated before January 2025

Company Overview

Henry Schein, Inc. (HSIC) is a leading global distributor of healthcare products and services, primarily catering to dental and medical professionals. Founded in 1932 by Henry Schein in Queens, New York, the company began as a small pharmacy and has since grown into a Fortune 500 company with operations in over 30 countries. Headquartered in Melville, New York, Henry Schein serves more than one million customers worldwide. The company is led by Stanley M. Bergman, who has been the Chairman of the Board and Chief Executive Officer since 1989. Under his leadership, Henry Schein has expanded its global footprint and diversified its product and service offerings.

Core Business Segments

Henry Schein operates through three primary business segments:

1. Dental Products and Services

Henry Schein is a market leader in dental supplies and services, offering a comprehensive range of products for dental professionals. Key offerings include:

  • Consumables: Dental instruments, restorative materials, and infection control products.
  • Equipment: Dental chairs, imaging systems, and CAD/CAM systems.
  • Services: Practice management software, equipment repair, and financial services tailored for dental practices.

2. Medical Products and Services

The company provides a wide array of medical products and services to healthcare providers, including:

  • Consumables: Gloves, syringes, and diagnostic kits.
  • Equipment: Diagnostic devices, sterilization systems, and surgical instruments.
  • Services: Inventory management, consulting, and technology solutions for medical practices.

3. Technology and Value-Added Services

Henry Schein offers technology solutions and value-added services to enhance the efficiency of healthcare practices. These include:

  • Practice Management Software: Tools for scheduling, billing, and patient records management.
  • E-commerce Solutions: Online platforms for ordering supplies and managing inventory.
  • Consulting Services: Business and financial advisory services for healthcare providers.

Business Model

Henry Schein operates a highly integrated business model that combines product distribution with value-added services. The company sources products from a vast network of manufacturers and distributes them through its extensive logistics network. Revenue is generated through product sales, service fees, and subscription-based technology solutions. By offering a one-stop solution for healthcare professionals, Henry Schein fosters long-term customer relationships and ensures a steady revenue stream.

Strategic Direction

Henry Schein is focused on driving growth through innovation, sustainability, and strategic acquisitions. Key strategic initiatives include:

  • Expansion of Digital Solutions: Investing in advanced technologies like artificial intelligence and cloud-based software to enhance practice management.
  • Sustainability Goals: Committing to environmentally friendly practices, such as reducing packaging waste and promoting energy-efficient products.
  • New Product Categories: Exploring opportunities in emerging healthcare markets, such as telemedicine and home healthcare.
  • Global Expansion: Strengthening its presence in high-growth markets, particularly in Asia and Latin America.

Competitive Landscape

Henry Schein operates in a highly competitive market, facing competition from both large multinational corporations and smaller regional players. Key competitors include:

  • Patterson Companies, Inc.: A major competitor in the dental and veterinary supply markets.
  • McKesson Corporation: A leading distributor of medical supplies and pharmaceuticals.
  • Cardinal Health: A global healthcare services and products company.
  • Benco Dental: A privately-owned dental distributor in the U.S.

Despite the competition, Henry Schein differentiates itself through its comprehensive product portfolio, strong customer relationships, and focus on innovation.

Risk Factors

Henry Schein faces several risks that could impact its business operations and financial performance:

  • Market Dependence: Reliance on the dental and medical markets makes the company vulnerable to economic downturns and changes in healthcare regulations.
  • Supply Chain Disruptions: Dependence on third-party manufacturers and global supply chains exposes the company to risks such as delays, shortages, and price fluctuations.
  • Technological Risks: Rapid advancements in technology require continuous investment in innovation to stay competitive.
  • Regulatory Compliance: Operating in multiple countries necessitates compliance with diverse and evolving regulations, which can be challenging and costly.

Recent Developments

Henry Schein has recently introduced several initiatives and products to strengthen its market position:

  • Digital Dentistry Solutions: Launching new CAD/CAM systems and 3D printing technologies to enhance dental practices.
  • Sustainability Initiatives: Partnering with manufacturers to offer eco-friendly products and reduce carbon emissions.
  • Strategic Acquisitions: Acquiring regional distributors and technology companies to expand its product offerings and geographic reach.
  • COVID-19 Response: Playing a critical role in distributing personal protective equipment (PPE) and COVID-19 testing kits during the pandemic.

Investment Considerations

Strengths:

  • Market Leadership: Strong position in the dental and medical supply markets.
  • Diverse Product Portfolio: Comprehensive range of products and services.
  • Global Presence: Operations in over 30 countries provide geographic diversification.
  • Innovation: Continuous investment in technology and digital solutions.

Risks:

  • Economic Sensitivity: Vulnerability to economic downturns and healthcare spending cuts.
  • Regulatory Challenges: Compliance with complex regulations across multiple jurisdictions.
  • Supply Chain Risks: Dependence on third-party manufacturers and global logistics.

Conclusion

Henry Schein, Inc. is a well-established leader in the healthcare distribution industry, with a strong focus on innovation, customer service, and sustainability. The company’s integrated business model and global presence position it for continued growth. However, investors should consider the risks associated with market dependence, regulatory compliance, and supply chain disruptions. Overall, Henry Schein remains a compelling choice for healthcare professionals and investors alike, with a promising outlook for future growth.